Target intelligence / Profile preview

Caveolae-associated protein 3 (CAVIN3)

Target
CAVIN3
Molecular classification
Adapter protein, Caveolar protein, Signal transduction modulator, Other
01

Overview

Caveolae-associated protein 3 (CAVIN3), also known as SRBC or PRKCDBP, is an adapter and structural protein critical for the formation and function of caveolae—small, flask-shaped invaginations of the plasma membrane involved in signal transduction and membrane trafficking. CAVIN3 is part of the cavin protein family (which includes CAVIN1, CAVIN2, and CAVIN4), and helps link signaling molecules such as protein kinase C (PKC) to membrane compartments for signal regulation. CAVIN3 is frequently epigenetically silenced in diverse cancers via promoter methylation, and its loss impairs apoptosis and DNA repair, partly by directly interacting with BRCA1 and influencing homologous recombination DNA repair pathways. CAVIN3-deficient cells are more sensitive to PARP inhibition and display increased genomic instability, highlighting its tumor suppressor role and potential as a biomarker for cancer diagnosis, prognosis, and therapy stratification. No direct drug interactions or therapies targeting CAVIN3 have been described, but loss of function may inform the use of DNA repair-targeting drugs such as PARP inhibitors in oncology.

Other names
CAVIN3PRKCDBPSRBChSRBCcavin-3Protein kinase C delta-binding proteinSerum deprivation response factor-related gene product that binds to C-kinasesdr-related gene product that binds to c-kinaseMGC20400
02

Mechanism of action

Modulation of DNA repair pathways (e.g. BRCA1-dependent homologous recombination); Sensitization to PARP inhibitors when CAVIN3 is deleted; Not a direct drug target currently

03

Biological functions

Regulation of caveolae structure and traffickingModulation of DNA repair (BRCA1 interaction)Regulation of apoptosisModulation of cell proliferationSignal transduction (e.g. PKC pathway regulation)Regulation of EGFR traffickingOther
04

Disease associations

Cancer (notably silenced in several tumor types, including breast and ovarian cancer)Genomic instability syndromesOther
05

Safety considerations

No direct therapeutic targeting described; possible concerns would relate to impaired DNA repair, potential increased genomic instability, and apoptotic response modulation if CAVIN3 modulation were used therapeutically
06

Interacting drugs

None directly identified in search results. (PARP inhibitors can target cells with CAVIN3 deletion or BRCA1 dysfunction, but CAVIN3 itself is not a direct drug target so far)
07

Biomarkers

CAVIN3 silencing/methylation as a tumor biomarker (especially for breast, ovarian, and other cancers)CAVIN3 loss indicative of increased PARP inhibitor sensitivity (by analogy with BRCA1-deficiency)

Beyond the preview

Go deeper on Caveolae-associated protein 3 (CAVIN3).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Caveolae-associated protein 3 (CAVIN3).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call